225 related articles for article (PubMed ID: 21973)
1. Protective efficacy of pneumococcal polysaccharide vaccines.
Smit P; Oberholzer D; Hayden-Smith S; Koornhof HJ; Hilleman MR
JAMA; 1977 Dec; 238(24):2613-6. PubMed ID: 21973
[TBL] [Abstract][Full Text] [Related]
2. Polyvalent pneumococcal polysaccharide vaccines.
Hilleman MR; McLean AA; Vella PP; Weibel RE; Woodhour AF
Bull World Health Organ; 1978; 56(3):371-5. PubMed ID: 28857
[TBL] [Abstract][Full Text] [Related]
3. [Serotype 5 pneumococcus in epidemiology and vaccine].
Lafaix C; Meignan S; Biron G; Armand J
Bull Eur Physiopathol Respir; 1983; 19(2):195-7. PubMed ID: 6871497
[TBL] [Abstract][Full Text] [Related]
4. Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes.
Friedman EA; Beyer MM; Hirsch SR; Schiffman G
JAMA; 1980 Nov; 244(20):2310-1. PubMed ID: 7431555
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal vaccine and otitis media.
Mäkelä PH; Sibakov M; Herva E; Henrichsen J; Luotonen J; Timonen M; Leinonen M; Koskela M; Pukander J; Pöntynen S; Grönroos P; Karma P
Lancet; 1980 Sep; 2(8194):547-51. PubMed ID: 6106735
[TBL] [Abstract][Full Text] [Related]
6. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
Shapiro ED; Berg AT; Austrian R; Schroeder D; Parcells V; Margolis A; Adair RK; Clemens JD
N Engl J Med; 1991 Nov; 325(21):1453-60. PubMed ID: 1944423
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations.
Bruyn GA; van Furth R
Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):897-910. PubMed ID: 1794358
[TBL] [Abstract][Full Text] [Related]
8. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae.
Swiatlo E; Ware D
FEMS Immunol Med Microbiol; 2003 Aug; 38(1):1-7. PubMed ID: 12900048
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients.
Katz LA; Simberkoff MS; Schiffman G; Spicehandler JR; Moldover NH; Rahal JJ
Trans Am Soc Artif Intern Organs; 1980; 26():369-71. PubMed ID: 7245515
[No Abstract] [Full Text] [Related]
10. Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community.
Riley ID; Tarr PI; Andrews M; Pfeiffer M; Howard R; Challands P; Jennison G
Lancet; 1977 Jun; 1(8026):1338-41. PubMed ID: 69058
[TBL] [Abstract][Full Text] [Related]
11. Prevention of pneumococcal pneumonia by immunization with pneumococcal polysaccharide vaccine (Pneumovax).
Helms CM
J Iowa Med Soc; 1978 Aug; 68(8):282-3. PubMed ID: 29072
[No Abstract] [Full Text] [Related]
12. Antibody responses against pneumococcal polysaccharide antigens in vaccinated persons.
Leinonen M
Ann Clin Res; 1982 Dec; 14(5-6):267-71. PubMed ID: 7171234
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of CRM₁₉₇ conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants.
Mallet E; Brachet E; Fernsten P; Laudat F; Razmpour A; Gruber WC;
Vaccine; 2011 Aug; 29(34):5812-9. PubMed ID: 21296118
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.
Breiman RF; Keller DW; Phelan MA; Sniadack DH; Stephens DS; Rimland D; Farley MM; Schuchat A; Reingold AL
Arch Intern Med; 2000 Sep; 160(17):2633-8. PubMed ID: 10999977
[TBL] [Abstract][Full Text] [Related]
15. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
Austrian R
J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
[TBL] [Abstract][Full Text] [Related]
16. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
17. Planning for a second (23 valent) generation pneumococcal vaccine. With special reference to new developments in our understanding of the structure and biology of polysaccharides.
Robbins JB; Schneerson R
Bull Eur Physiopathol Respir; 1983; 19(2):215-26. PubMed ID: 6347282
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal infections and the possible need for a vaccine.
Kaijser B
Scand J Infect Dis; 1979; 11(3):179-84. PubMed ID: 93308
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.
Simberkoff MS; Cross AP; Al-Ibrahim M; Baltch AL; Geiseler PJ; Nadler J; Richmond AS; Smith RP; Schiffman G; Shepard DS
N Engl J Med; 1986 Nov; 315(21):1318-27. PubMed ID: 3534568
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
Kim KH; Seoh JY
J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
